X0306 4 2018-11-02 0 0000884624 Orthofix Medical Inc. OFIX 0001248184 FAULSTICK LUKE T 3451 PLANO PARKWAY LEWISVILLE TX 75056 1 0 0 0 Common Stock 2018-11-02 4 S 0 3500 60.9271 D 7129 D Common Stock 2018-11-02 4 S 0 650 61.7243 D 6479 D Common Stock 2018-11-02 4 M 0 4300 32.13 A 10779 D Common Stock 2018-11-02 4 S 0 3600 60.9251 D 7179 D Common Stock 2018-11-02 4 S 0 700 61.7357 D 6479 D Stock Option (right to buy) 32.13 2018-11-02 4 M 0 4300 0.00 D 2024-09-17 Common Stock 4300 25700 D The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.54 to $61.39, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.61 to $61.87, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.51 to $61.39, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.62 to $61.87, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4. These stock options vest in 25% increments on each of September 17, 2015, 2016, 2017 and 2018. /s/ Kimberley A. Elting, Chief Legal and Administrative Officer, by power of attorney 2018-11-06